MedPath

Performance of Whole Body MRI in Extraplevic Disease Detection in Patients Undergoing Pelvic Exenteration for Gynecological Maligniancies

Recruiting
Conditions
Gynecologic Cancer
Registration Number
NCT05816005
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The aim of this prospective observational diagnostic study is to investigate the diagnostic accuracy od extrapelvic disease detection using Whole-body-MRI (WB-MRI) in patients with gynecologic cancer candidate to the pelvic exenteration.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
71
Inclusion Criteria
  • Age > 18 years
  • Written Informed Consent
  • All patients with recurrent gynecological cancer that are planned to undergo pelvic exenteration or laterally extended pelvic resection, both with curative and palliative intent
  • Patients considered fit for srugery
Read More
Exclusion Criteria
  • Controindication to MRI (Claustrophobia, implanted ferromagnetic materials or foreign objects, Known intolerance or controindication to the MRI contrast agent, cardiac pacemaker)
  • Individuals who are not able or willing to tolerate the required prologed stationary supine position during examination (approximately 40-60 minutes)
  • Patient unable to give informed consent
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of diagnostic accuracy for extrapelvic disease detection using whole-body MRIThrough study completion, an average of 2 yearS
Secondary Outcome Measures
NameTimeMethod
Agreement between WB-MRI and PET-CT in detecting extrapelvic involvementThrough study completion, an average of 2 yearS

Trial Locations

Locations (1)

Fondazione Policlinico Universitaro "A. Gemelli" IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath